Profil
G.
Shankar Gopalakrishnan is currently Operating Partner at MOPE Investment Advisors Pvt Ltd. Formerly, Mr. Gopalakrishnan was Director at Symbiotec Pharmalab Ltd. from 2018 to 2025 and Vice President-Finance at Hikal Ltd.
Postes actifs de G. Gopalakrishnan
| Sociétés | Poste | Début |
|---|---|---|
MOPE Investment Advisors Pvt Ltd.
MOPE Investment Advisors Pvt Ltd. Investment ManagersFinance MOPE invests in middle market private and public companies located in India. The firm focuses on sectors such as consumer, financial services, life sciences and niche manufacturing. It participates in growth stage capital transactions and it acquires minority stake. | Consultant / Advisor | 01/01/2013 |
Anciens postes connus de G. Gopalakrishnan
| Sociétés | Poste | Fin |
|---|---|---|
Symbiotec Pharmalab Pvt Ltd.
Symbiotec Pharmalab Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Directeur/Membre du Conseil | 27/11/2025 |
| HIKAL LIMITED | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hikal Ltd.
Hikal Ltd. Pharmaceuticals: MajorHealth Technology Engages in manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities | Health Technology |
Symbiotec Pharmalab Pvt Ltd.
Symbiotec Pharmalab Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
MOPE Investment Advisors Pvt Ltd.
MOPE Investment Advisors Pvt Ltd. Investment ManagersFinance MOPE invests in middle market private and public companies located in India. The firm focuses on sectors such as consumer, financial services, life sciences and niche manufacturing. It participates in growth stage capital transactions and it acquires minority stake. | Finance |
















